Block Biosciences
1 known investors
Find your way into Block Biosciences
Sign up to see every warm intro you have to Block Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Block Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Block Biosciences develops first-in-class therapeutics designed to intercept the spread of cancer to the brain by inhibiting a step in the purine biosynthesis pathway involved in brain metastasis. The company designs blood-brain-barrier-permeable inhibitors using a library of clinically-relevant brain metastasis models.
Investors · 1
Frequently asked questions
- What does Block Biosciences do?
- Block Biosciences develops first-in-class therapeutics designed to intercept the spread of cancer to the brain by inhibiting a step in the purine biosynthesis pathway involved in brain metastasis. The company designs blood-brain-barrier-permeable inhibitors using a library of clinically-relevant brain metastasis models.
- Who are Block Biosciences's investors?
- Block Biosciences's investors include FACIT (Fight Against Cancer Innovation Trust).